The therapeutic benefit of vasodilators in acute heart failure: absence of evidence or evidence of absence?-Reference-Cited by-同舟云学术

The therapeutic benefit of vasodilators in acute heart failure: absence of evidence or evidence of absence?

Published:2022-10-13 Issue:11 Volume:11 Page:861-864
ISSN:2048-8726
Container-title:European Heart Journal. Acute Cardiovascular Care
language:en
Short-container-title:

Author:

Coughlan J J¹²^ORCID,Ibanez Borja³⁴⁵^ORCID

Affiliation:

1. Department of Cardiology, Deutsches Herzzentrum München und Technische Universität München , Lazarettstraße 36, 80636 München , Germany

2. Cardiovascular Research Institute, Mater Private Network , 73 Eccles Street, Dublin 7, D07 KWR1 , Ireland

3. Centro Nacional de Investigaciones Cardiovasculares Carlos III , c/Melchor Fernandez Almagrom 3, Madrid 28029 , Spain

4. IIS-Fundación Jiménez Díaz University Hospital , Madrid 28040 , Spain

5. CIBER de enfermedades cardiovasculares (CIBERCV) , Madrid 28029 , Spain

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,General Medicine

Link

https://academic.oup.com/ehjacc/advance-article-pdf/doi/10.1093/ehjacc/zuac130/46564205/zuac130.pdf

Reference15 articles.

1. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

2. Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial;Kozhuharov;JAMA,2019

3. Effect of an emergency department care bundle on 30-day hospital discharge and survival among elderly patients with acute heart failure: the ELISABETH randomized clinical trial;Freund;JAMA,2020

4. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group;Colucci;N Engl J Med,2000

5. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial;Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF);JAMA,2002